Form 8-K UNITED THERAPEUTICS Corp For: Jul 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
United Therapeutics (UTHR) Tops Q2 EPS Expectations
July 29, 2014 6:28 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $2.57, $0.82 better than the analyst estimate of $1.75. Revenue for the quarter came in at $322.8 million versus the consensus estimate of $308.04 million.
"Our continued growth shows that our medicines are reaching increasing numbers of patients suffering from pulmonary... More
